Medicinal Cannabis : GI and Hepatic Disorders
This module, Medicinal Cannabis: GI and Hepatic Disorders, presents information on the use of medicinal cannabis in this topic area, and will cover: introduction to the disorders that will be discussed; overview of current treatments and their effectiveness; evidence and basic science rationale for medicinal cannabis use in this area; risks and benefits, including drug interactions; and recommendations for appropriate use (form, strain, ratios, doses, frequency). The module will provide supplementary materials for further study.
A Note About Registration
|IMPORTANT BROWSER INFO: This site will not work properly on Internet Explorer 8. Please use: Chrome Firefox Safari|
Learning Objectives & Target Audience
- Outline the endocannabinoid system's role in GI and Hepatic Disorders.
- Summarize current evidence both for and against cannabis use in GI and Hepatic Disorders.
- Explain the efficacy / lack of efficacy of currently approved therapeutic options for specific GI and Hepatic Disorders.
- Describe the risks and benefits of medicinal cannabinoids in GI and Hepatic Disorders.
- Discuss cannabinoid interactions with other medications.
- Discuss best practices for selection of cannabis forms, strains, ratios and dosages in specific GI and Hepatic Disorders.
Planners and Presenters:
Larry Good, MD
Assistant Clinical Professor of Medicine
SUNY Stony Brook
Stony Brook, NY
Charles Pollack, MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP
Associate Provost for Innovation in Education
Director, Jefferson Institute of Emerging Health Professions
Director, The Lambert Center for the Study of Medicinal Cannabis and Hemp
Associate Dean for CME and Strategic Partner Alliances
Thomas Jefferson University
Judy Spahr, MPH, MLS, MEd, CCRC, CCRP
Administrative Director, The Lambert Center for the Study of Medicinal Cannabis and Hemp
Thomas Jefferson University
This course is open to all interested learners. If you are seeking CE credit, the accreditation requirements for successful completion are: You must register and complete the entire online program, viewing the video in its entirety, obtaining a successful post test score of at least 80%, and completing the online evaluation, in order to receive full credit for this course. Once these components are completed, you will immediately be able to access your CE Certificate.
If you have any questions, please contact us at JeffersonCPD@jefferson.edu.
Sidney Kimmel Medical College at Thomas Jefferson University designates this enduring material activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Contact Hours: RN participants who successfully complete this activity will be awarded maximum 1 contact hour.
Non-endorsement of products: Accreditation refers to recognition of continuing nursing education activities only and does not imply Pennsylvania State Nurses Association or ANNC Commission on Accreditation approval or endorsement of any commercial products.
This knowledge based program ( 0079-9999-018-008-H01-P) is acceptable for 1.0 hour of continuing pharmacy education credit. Statements of Credit indicating hours/CEUs will be uploaded to CPE Monitor within 60 days following program for participants who complete this activity and submit required participant information, including evaluation, pre/post-test, NABP # and DOB.
The American Academy of Physician Assistants accepts AMA PRA Category 1 Credits™
If you have any questions regarding CE credits for this particular course, please contact us at JeffersonCPD@jefferson.edu.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
- 1.00 CNE
- 1.00 ACPE
- 1.00 ACPE-T
Internet Connection and Audio Source